psycho-social disorder (autonomy deficit) Selfdetermination selfgouvernance
Conditions
Interventions
In the experimental phase of the study the experimental group receives Autonomy
Enhancing Therapy and the control group receives standard audiological support.
- The experimental treatment, Autonomy
Sponsors
Leids Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Hearing loss in the best ear >= 35 dB and a clinically deviant score on at least one subscale ot the AGS-30 (below average score)
Exclusion criteria
Exclusion criteria: Receiving treatment for psychiatric problems or tinnitus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameters /endpoints, outcomes in the psychosocial and mental health domain are evaluated at the end of the experimental phase (T2) with standardized questionnaires. A questionnaire of autonomy-connectedness (Autonomy- Connectedness Scale-30, ACS-30) and questionnaires for anxiety disorder (Symptom Checklist 90-R, SCL-90-R) and depression (Beck Depression Inventory, BDI-II-NL). | — |
Secondary
| Measure | Time frame |
|---|---|
| In the secondary phase for clinical-therapeutical purposes the AET is provided to the control group. T3 assessment with standardized questionnaires of autonomy-connectedness and mental disorders is performed to verify effect of therapy for the control group. In case of persisting autonomy-connectedness or mental health disorders these assessments are necessary for referral for further psychological care. In the experimental group T3 the Autonomy-Connectedness scale-30 (ACS-30) is used to assess the retention effect of AET in the experimental group. | — |
Countries
Netherlands
Outcome results
None listed